{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:15:04Z","timestamp":1774991704833,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1016\/s0049-3848(01)00331-0","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T10:07:20Z","timestamp":1027591640000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Activity and Antigen Levels of Thrombin-Activatable Fibrinolysis Inhibitor in Plasma of Patients With Disseminated Intravascular Coagulation"],"prefix":"10.1016","volume":"104","author":[{"given":"Rika","family":"Watanabe","sequence":"first","affiliation":[]},{"given":"Hideo","family":"Wada","sequence":"additional","affiliation":[]},{"given":"Yasuyuki","family":"Watanabe","sequence":"additional","affiliation":[]},{"given":"Miho","family":"Sakakura","sequence":"additional","affiliation":[]},{"given":"Takahiro","family":"Nakasaki","sequence":"additional","affiliation":[]},{"given":"Yoshitaka","family":"Mori","sequence":"additional","affiliation":[]},{"given":"Masakatsu","family":"Nishikawa","sequence":"additional","affiliation":[]},{"given":"Esteban C.","family":"Gabazza","sequence":"additional","affiliation":[]},{"given":"Tsutomu","family":"Nobori","sequence":"additional","affiliation":[]},{"given":"Hiroshi","family":"Shiku","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0049-3848(01)00331-0_BIB1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0038-1657557","article-title":"Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis","volume":"78","author":"Nesheim","year":"1997","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/S0049-3848(01)00331-0_BIB2","doi-asserted-by":"crossref","first-page":"16603","DOI":"10.1074\/jbc.271.28.16603","article-title":"TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin\u2013thrombomodulin complex","volume":"271","author":"Bajar","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/S0049-3848(01)00331-0_BIB3","first-page":"277","article-title":"Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidases N","volume":"27","author":"Hendrinks","year":"1989","journal-title":"J Clin Chem Clin Biochem"},{"key":"10.1016\/S0049-3848(01)00331-0_BIB4","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118315","article-title":"Plasma carboxypeptides as regulators of the plasminogen system","volume":"96","author":"Redlitz","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/S0049-3848(01)00331-0_BIB5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00000658-198512000-00004","article-title":"Prognosis in acute organ-system failure","volume":"202","author":"William","year":"1985","journal-title":"Ann Surg"},{"key":"10.1016\/S0049-3848(01)00331-0_BIB6","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/archsurg.1975.01360130011001","article-title":"Multiple progressive or sequential systems failure","volume":"110","author":"Baue","year":"1975","journal-title":"Arch Surg"},{"key":"10.1016\/S0049-3848(01)00331-0_BIB7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1055\/s-0038-1646614","article-title":"Plasminogen activator inhibitor 1. A new prognostic marker in septic shock","volume":"61","author":"Pralong","year":"1989","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/S0049-3848(01)00331-0_BIB8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1172\/JCI111777","article-title":"Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation","volume":"75","author":"Colucci","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/S0049-3848(01)00331-0_BIB9","first-page":"265","article-title":"Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan","volume":"49","author":"Kobayashi","year":"1987","journal-title":"Biol Haematol"},{"key":"10.1016\/S0049-3848(01)00331-0_BIB10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ajh.2830430306","article-title":"Hemostatic study before onset of disseminated intravascular coagulation","volume":"43","author":"Wada","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/S0049-3848(01)00331-0_BIB11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/(SICI)1096-8652(199904)60:4<273::AID-AJH4>3.0.CO;2-N","article-title":"Hemostatic molecular makers before the onset of disseminated intravascular coagulation","volume":"60","author":"Wada","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/S0049-3848(01)00331-0_BIB12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ajh.2830390106","article-title":"Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation","volume":"39","author":"Wada","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1016\/S0049-3848(01)00331-0_BIB13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1365-2141.2000.01890.x","article-title":"Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukemia","volume":"108","author":"Meijers","year":"2000","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/S0049-3848(01)00331-0_BIB14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2007-995821","article-title":"Derangements of coagulation and fibrinolysis in critically 3 patients with sepsis and septic shock","volume":"24","author":"Marc","year":"1998","journal-title":"Semin Thromb Hemostasis"},{"key":"10.1016\/S0049-3848(01)00331-0_BIB15","first-page":"2855","article-title":"Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis","volume":"95","author":"Tilburg","year":"2000","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/S0049-3848(01)00331-0_BIB16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1055\/s-0037-1614029","article-title":"Plasma procarboxypeptidase U in men with symptomatic artery disease","volume":"84","author":"Silveira","year":"2000","journal-title":"Thromb Haemostasis"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384801003310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384801003310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:33:48Z","timestamp":1758735228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384801003310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S0049384801003310"],"URL":"https:\/\/doi.org\/10.1016\/s0049-3848(01)00331-0","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity and Antigen Levels of Thrombin-Activatable Fibrinolysis Inhibitor in Plasma of Patients With Disseminated Intravascular Coagulation","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0049-3848(01)00331-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Elsevier Science Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}